BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$615M |
| 2 |
State Street SPDR S&P Retail ETF
XRT
|
+$231M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$229M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$186M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$620M |
| 3 |
Tesla
TSLA
|
+$594M |
| 4 |
Apple
AAPL
|
+$541M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.24% |
| 2 | Financials | 6.85% |
| 3 | Healthcare | 5.31% |
| 4 | Consumer Discretionary | 4.97% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Forestar Group
FOR
$1.51B
| $89.8K | ﹤0.01% |
4,819
+2,631
| +120% | +$53.1K |
|
3177
Noodles & Co
NDLS
$100M
| $89.7K | ﹤0.01% |
950
+753
| +382% | +$73.7K |
|
3178
CAE Inc. Common Shares
CAE
$8.47B
| $89.6K | ﹤0.01% |
3,000
| – | – |
|
|
BCOV
3179
DELISTED
Brightcove, Inc.
BCOV
| $89.1K | ﹤0.01% |
7,720
+6,259
| +428% | +$75.6K |
|
3180
Atomera
ATOM
$212M
| $88.7K | ﹤0.01% |
3,840
+3,029
| +373% | +$65.7K |
|
3181
Atossa Therapeutics
ATOS
$25.5M
| $88.5K | ﹤0.01% |
1,809
+1,110
| +159% | +$64.6K |
|
|
NPKI
3182
NPK International
NPKI
$1.18B
| $88.4K | ﹤0.01% |
26,773
+9,782
| +58% | +$27.6K |
|
3183
KT
KT
$9.03B
| $88.1K | ﹤0.01% |
6,472
| – | – |
|
3184
Sierra Bancorp
BSRR
$532M
| $88K | ﹤0.01% |
3,625
+1,802
| +99% | +$43.8K |
|
|
CLVS
3185
DELISTED
Clovis Oncology, Inc.
CLVS
| $87.9K | ﹤0.01% |
19,709
+16,123
| +450% | +$77.7K |
|
3186
iShares MSCI Switzerland ETF
EWL
$2.22B
| $87.4K | ﹤0.01% |
+1,876
| New | +$93.1K |
|
3187
Seres Therapeutics
MCRB
$45M
| $87.2K | ﹤0.01% |
626
+495
| +378% | +$96.9K |
|
|
TBCH
3188
Turtle Beach Corp
TBCH
$230M
| $86.9K | ﹤0.01% |
3,122
+1,904
| +156% | +$55.5K |
|
3189
AXT Inc
AXTI
$5.07B
| $86.7K | ﹤0.01% |
10,408
+5,089
| +96% | +$47.4K |
|
|
AERI
3190
DELISTED
Aerie Pharmaceuticals
AERI
| $86.5K | ﹤0.01% |
7,591
+5,932
| +358% | +$86.7K |
|
3191
Kodak
KODK
$978M
| $86K | ﹤0.01% |
12,624
+10,543
| +507% | +$77K |
|
3192
Spyre Therapeutics
SYRE
$8.98B
| $85.5K | ﹤0.01% |
430
+242
| +129% | +$42.3K |
|
|
BFX
3193
DELISTED
BowFlex Inc.
BFX
| $85.4K | ﹤0.01% |
9,177
+5,290
| +136% | +$67.9K |
|
3194
Rocky Brands
RCKY
$353M
| $84.6K | ﹤0.01% |
1,777
+1,007
| +131% | +$50.1K |
|
|
BNFT
3195
DELISTED
Benefitfocus, Inc.
BNFT
| $84.6K | ﹤0.01% |
7,619
+4,891
| +179% | +$59.4K |
|
|
TCS
3196
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $84.5K | ﹤0.01% |
592
+165
| +39% | +$27.7K |
|
|
RPT
3197
Rithm Property Trust
RPT
$101M
| $84.5K | ﹤0.01% |
1,044
+354
| +51% | +$28.4K |
|
|
EGIO
3198
DELISTED
Edgio, Inc. Common Stock
EGIO
| $84.1K | ﹤0.01% |
883
+405
| +85% | +$42.7K |
|
|
EPZM
3199
DELISTED
Epizyme, Inc
EPZM
| $83.9K | ﹤0.01% |
16,381
+12,953
| +378% | +$78.7K |
|
|
PRVB
3200
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $83.8K | ﹤0.01% |
13,092
+6,278
| +92% | +$40.3K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2021 Portfolio in Review
As of Q3 2021, BNP Paribas Financial Markets held 4,161 positions worth $70.6B, down 6.6% from $75.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.5B in Q3 2021, closing 150 positions and reducing 1,194 holdings. Its most notable exit was GE Aerospace, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares 10+ Year Investment Grade Corporate Bond ETF worth $5.86M.
- BNP Paribas Financial Markets's largest Q3 2021 buy was iShares 10+ Year Investment Grade Corporate Bond ETF: 84,600 shares worth $5.86M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2021, an estimated $615M increase.
- BNP Paribas Financial Markets's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.24B.
- BNP Paribas Financial Markets fully exited GE Aerospace in Q3 2021, selling an estimated $147M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $70.6B portfolio in Q3 2021.
- BNP Paribas Financial Markets opened 102 new positions and closed 150 in Q3 2021.
- BNP Paribas Financial Markets's portfolio value fell 6.6% quarter-over-quarter to $70.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.